Skip to main content

Advertisement

Log in

Multiple endocrine neoplasia type 2 with malignant pheochromocytoma — Long term follow-up of a case by131I-meta-iodobenzylguanidine scintigraphy—

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

The case of a 33-year-old Japanese man, who has Multiple Endocrine Neoplasia Type 2 (MEN IIa) (Sipple’s syndrome) with malignant pheochromocytoma, is reported. He had survived for twelve years since the initial diagnosis of malignant pheochromocytoma. Within this period, he had undergone131I-meta-iodobenzylguanidine scintigraphy twice, in 1983 and 1990. This is the first case in Japan of a longterm surviving patient with malignant pheochromocytoma followed up by131I-MIBG scintigraphy. Although he had no exacerbation of clinical symptoms or urinary catecholamine levels, second scintigraphy clearly showed an increase in the tumor size, new metastasis of the malignant pheochromocytoma and exacerbation of the medullary thyroid carcinoma. Compared with any other roentgenological device and hormonal data,131I-MIBG scintigraphy was seen to be a good tool for evaluating the localization and the progression of tumors.131I-MIBG scintigraphy is a useful procedure not only for initial diagnosis but also for judging progression in a case of advanced malignant pheochromocytoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Manger WM, Gifford RW: Hypertension secondary to pheochromocytoma.Bull NY Acad Med 58: 139–158, 1982

    CAS  Google Scholar 

  2. VanHeerden JA, Sheps SG, Hamberger B, et al: Pheochromocytoma: Current status and changing trends.Surgery 91: 367–373, 1982

    CAS  Google Scholar 

  3. Freier DT, Eckhauser FE and Harrison FS: Pheochromocytoma: A persistently problematic and still potentially lethal disease.Arch Surg 115: 388–391, 1980

    PubMed  CAS  Google Scholar 

  4. Bravo EL, Tarazi RC, Gifford RW, et al: Circulating and urinary catecholamines in pheochromocytoma: Diagnostic and pathophysiological implications.N Engl J Med 301: 682–686, 1979

    PubMed  CAS  Google Scholar 

  5. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.N Engl J Med 303: 436–444, 1980

    PubMed  CAS  Google Scholar 

  6. Stewart BH, Brown EL, Haagu J, et al: Localization of pheochromocytoma by computed tomography.N Engl J Med 299: 460–461, 1978

    PubMed  CAS  Google Scholar 

  7. Laursen K, Gamgaard-Pedersen K: CT for pheochromocytoma diagnosis.Am J Roentgenol 134: 277–280, 1980

    CAS  Google Scholar 

  8. Sisson JC, Frager MS, Valk TW, et al: Scintigraphic localization of pheochromocytoma.N Engl J Med 305: 12–17, 1981

    PubMed  CAS  Google Scholar 

  9. Valk TW, Frager MS, Gross MD, et al: Spectrum of pheochromocytoma in multiple endocrine neoplasia: A scintigraphic portrayal using 131-I-metaiodobenzylguanidine.Ann Int Med 94: 762–767, 1981

    PubMed  CAS  Google Scholar 

  10. Sisson JC, Shapiro B, Beierwaltes WH, et al: Radiopharmaceutical treatment of malignant pheochromocytoma.J Nucl Med 24: 197–206, 1984

    Google Scholar 

  11. Shapiro B, Copp JE, Sisson JC, et al: Iodine-131 Metaiodobenzylguanidine for the locating of suspected Pheochromocytoma: Experience in 400 cases.J Nucl Med 26: 576–585, 1985

    PubMed  CAS  Google Scholar 

  12. Izumi M, Morimoto I, Yamashita S, et al: 131I-Metaiodobenzylguanidine scintigraphy. Controversies in disorders of adrenal hormones.Elsevier Science Publishers B.V. 217–228, 1988

  13. Remine WH, Chong GC, Van Heerden JA, et al: Current management of pheochromocytoma.Ann Surg 179: 740–748, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Modlin IM, Fandon JR, Shepherd A, et al: Pheochromocytoma in 22 patients: Clinical and diagnostic features, treatment and longterm results.Br J Surg 66: 456–465, 1979

    Article  PubMed  CAS  Google Scholar 

  15. Palmieri G, Ikkos D, Luft R: Malignant pheochromocytoma.Acta endocrinologica 36: 549–560, 1961

    PubMed  CAS  Google Scholar 

  16. Javadpour N, Woltering EA, Brennan MF: Adrenal neoplasms.Curr Probl Surg 17: 5–52, 1980

    Article  Google Scholar 

  17. Shapiro B, Sisson JC, Lloyd R: Malignant pheochromocytoma; clinical biochemical and scintigraphic characterization.Clinical Endocrinology 20: 189–203, 1984

    Article  PubMed  CAS  Google Scholar 

  18. Beierwaltes WH: Update on basic research and clinical experience with metaiodobenzylguanidine.Med Pediatr Oncol 15: 163–169, 1987

    Article  PubMed  CAS  Google Scholar 

  19. Ellison GT, Mansberger JA, Mansberger AR: Malignant recurrent pheochromocytoma during pregnancy: Case report and review of the literature.Surgery 103: 484–489, 1988

    PubMed  CAS  Google Scholar 

  20. Sellwood RA, Wapnick S, Breckenridge A, et al: Recurrent pheochromocytoma.Br J Surg 57: 309–312, 1970

    Article  PubMed  CAS  Google Scholar 

  21. Francis IR, Glazer GM, Shapiro B, et al: Complementary roles of CT scanning and131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.Am J Roentgenol 141: 719–725, 1983

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Namba, H., Kondo, H., Yamashita, S. et al. Multiple endocrine neoplasia type 2 with malignant pheochromocytoma — Long term follow-up of a case by131I-meta-iodobenzylguanidine scintigraphy—. Ann Nucl Med 6, 111–115 (1992). https://doi.org/10.1007/BF03164652

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164652

Key words

Navigation